US Studies Testosterone Use for Menopausal Women
US health regulators are reviewing testosterone use for menopausal women, with experts split over whether a female-specific product is needed … Read More The post US Studies Testosterone Use for Menopausal Women appeared first on ProPakistani .
The US Food and Drug Administration is currently examining the potential use of testosterone for women experiencing menopause. During a public meeting on Thursday, various stakeholders discussed the hormone's potential benefits, risks, and safety concerns. The FDA has not yet approved any testosterone therapy for women, despite its off-label use for low sexual desire, also known as hypoactive sexual desire disorder or HSDD.
While some experts argue that women should have access to testosterone products specifically designed for them, others maintain that the available evidence only supports its use for postmenopausal women with HSDD, and not for broader claims about mood, cognition, or general well-being. Safety concerns, such as cardiovascular and breast cancer risks, have also been raised, along with the caution that oral testosterone should not be recommended due to its impact on cholesterol levels.
Possible side effects of testosterone therapy include acne, increased hair growth, voice deepening, and hair loss. The FDA has previously reviewed testosterone use in women but has never approved it due to limited long-term safety data. The agency's public comment period on this issue remains open until October 19.
Written by urgent.news from ProPakistani's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
